Pediatric Atopic Dermatitis: Update on the Treatment Options

1. Weidinger S, Novak N. Atopic dermatitis. Lancet. 2016;387(10023):1109–22.10.1016/S0140-6736(15)00149-XSearch in Google Scholar

2. Lara-Corrales I, Huang CM, Parkin PC, Rubio-Gomez GA, Posso-De Los Rios CJ, Maguire J, et al. Vitamin D Level and Supplementation in Pediatric Atopic Dermatitis: A Randomized Controlled Trial. J Cutan Med Surg; 2018.10.1177/120347541880574430336685Search in Google Scholar

3. Diluvio L, Dattola A, Cannizzaro MV, Franceschini C, Bianchi L. Clinical and confocal evaluation of avenanthramides-based daily cleansing and emollient cream in pediatric population affected by atopic dermatitis and xerosis. G Ital di Dermatologia e Venereol. 2019;154(1):32–6.10.23736/S0392-0488.18.06002-930207438Search in Google Scholar

4. Yan DC, Hung CH, Sy LB, Lue KH, Shih IH, Yang CY, et al. A randomized, double-blind, placebo-controlled trial assessing the oral administration of a heat-treated lactobacillus paracasei supplement in infants with atopic dermatitis receiving topical corticosteroid therapy. Skin Pharmacol Physiol. 2019;32(4):201–11.10.1159/00049943631117100Search in Google Scholar

5. Lisante TA, Nuñez C, Zhang P. Efficacy and safety of an over-the-counter 1% colloidal oatmeal cream in the management of mild to moderate atopic dermatitis in children: a double-blind, randomized, active-controlled study. J Dermatolog Treat. 2017;28(7):659–67.10.1080/09546634.2017.130356928366039Search in Google Scholar

6. Eichenfield LF, Tom WL, Chamlin SL, Feldman SR, Hanifin JM, Simpson EL, et al. Guidelines of care for the management of atopic dermatitis: Section 1. Diagnosis and assessment of atopic dermatitis Work Group. J Am Acad Dermatol. 2014;70(2):338–51..10.1016/j.jaad.2013.10.010441018324290431Search in Google Scholar

7. Abbasi S, Kamalinejad M, Babaie D, Shams SM, Sadr Z, Gheysari M, et al. A new topical treatment of atopic dermatitis in pediatric patients based on Ficus carica L. (Fig): A randomized, placebo-controlled clinical trial. Complement Ther Med. 2017;35(August):85–91.10.1016/j.ctim.2017.10.00329154073Search in Google Scholar

8. Stettler H, Kurka P, Kandzora J, Pavel V, Breuer M, Macura-Biegun A. A new topical panthenol-containing emollient for maintenance treatment of childhood atopic dermatitis: results from a multicenter prospective study. J Dermatolog Treat. 2017;28(8):774–9.10.1080/09546634.2017.132893828511614Search in Google Scholar

9. Wolter S, Price HN. Atopic Dermatitis. Pediatr Clin North Am [Internet]. 2014;61(2):241–60. Available from: http://dx.doi.org/10.1016/j.pcl.2013.11.00210.1016/j.pcl.2013.11.00224636644Search in Google Scholar

10. Taghavi Ardakani A, Farrehi M, Sharif MR, Ostadmohammadi V, Mirhosseini N, Kheirkhah D, et al. The effects of melatonin administration on disease severity and sleep quality in children with atopic dermatitis: A randomized, double-blinded, placebo-controlled trial. Pediatr Allergy Immunol. 2018;29(8):834–40.10.1111/pai.1297830160043Search in Google Scholar

11. Lee SC. Various diagnostic criteria for atopic dermatitis (AD): A proposal of Reliable Estimation of Atopic Dermatitis in Childhood (REACH) criteria, a novel questionnaire-based diagnostic tool for AD. J Dermatol. 2016;43(4):376–84.10.1111/1346-8138.1326426813749Search in Google Scholar

12. Chan S, Cornelius V, Chen T, Radulovic S, Wan M, Jahan R, et al. Atopic Dermatitis Anti-IgE Paediatric Trial (ADAPT): The role of anti-IgE in severe paediatric eczema: Study protocol for a randomised controlled trial. Trials. 2017;18(1):1–7.10.1186/s13063-017-1809-7536170428330497Search in Google Scholar

13. Licari A, Ruffinazzi G, De Filippo M, CastaGnoli R, Marseglia A, Agostinis F, et al. A starch, glycyrretinic, zinc oxide and bisabolol based cream in the treatment of chronic mild-to-moderate atopic dermatitis in children: A three-center, assessor blinded trial. Minerva Pediatr. 2017;69(6):470–5.10.23736/S0026-4946.17.05015-029181960Search in Google Scholar

14. Chang Y Sen, Lin MH, Lee JH, Lee PL, Dai YS, Chu KH, et al. Melatonin Supplementation for Children with Atopic Dermatitis and Sleep Disturbance: A Randomized Clinical Trial. JAMA Pediatr. 2016;170(1):35–42.10.1001/jamapediatrics.2015.309226569624Search in Google Scholar

15. Heeney DD, Gareau MG, Marco ML. Intestinal Lactobacillus in health and disease, a driver or just along for the ride? Curr Opin Biotechnol. 2018;49:140–7.Search in Google Scholar

16. 1Zhang Z, Lv J, Pan L, Zhang Y. Roles and applications of probiotic Lactobacillus strains. Appl Microbiol Biotechnol. 2018;102(19):8135–43.10.1007/s00253-018-9217-930032432Search in Google Scholar

17. Wang IJ, Wang JY. Children with atopic dermatitis show clinical improvement after Lactobacillus exposure. Clin Exp Allergy. 2015;45(4):779–87.10.1111/cea.1248925600169Search in Google Scholar

18. Wu YJ, Wu WF, Hung CW, Ku MS, Liao PF, Sun HL, et al. Evaluation of efficacy and safety of Lactobacillus rhamnosus in children aged 4–48 months with atopic dermatitis: An 8-week, double-blind, randomized, placebo-controlled study. J Microbiol Immunol Infect. 2017;50(5):684–92.10.1016/j.jmii.2015.10.00326733351Search in Google Scholar

19. Kwon SH, Lim CJ, Jung J, Kim HJ, Park K, Shin JW, et al. The effect of autophagy-enhancing peptide in moisturizer on atopic dermatitis: a randomized controlled trial. J Dermatolog Treat. 2019;30(6):558–64.10.1080/09546634.2018.154440730427231Search in Google Scholar

20. Mack DR, Ahrne S, Hyde L, Wei S, Hollingsworth MA. Extracellular MUC3 mucin secretion follows adherence of. Gut [Internet]. 2003;52:827–34.10.1136/gut.52.6.827177368712740338Search in Google Scholar

21. Navarro-Lopez V, Ramirez-Bosca A, Ramon-Vidal D, Ruzafa-Costas B, Genoves-Martinez S, Chenoll-Cuadros E, et al. Effect of oral administration of a mixture of probiotic strains on SCORAD index and use of topical steroids in young patients with moderate atopic dermatitis a randomized clinical trial. JAMA Dermatology. 2018;154(1):37–43.10.1001/jamadermatol.2017.3647583358229117309Search in Google Scholar

22. Zane LT, Kircik L, Call R, Tschen E, Draelos ZD, Chanda S, et al. Crisaborole topical ointment, 2% in patients ages 2 to 17 years with atopic dermatitis: A phase 1b, open-label, maximal-use systemic exposure study. Pediatr Dermatol. 2016;33(4):380–7.10.1111/pde.12872508476127193740Search in Google Scholar

23. Cadmus SD, Sebastian KR, Warren D, Hovinga CA, Croce EA, Reveles LA, et al. Efficacy and patient opinion of wet-wrap dressings using 0.1% triamcinolone acetonide ointment vs cream in the treatment of pediatric atopic dermatitis: A randomized split-body control study. Pediatr Dermatol. 2019;36(4):437–41.Search in Google Scholar

24. Chan S, Cornelius V, Cro S, Harper JI, Lack G. Treatment Effect of Omalizumab on Severe Pediatric Atopic Dermatitis: The ADAPT Randomized Clinical Trial. JAMA Pediatr. 2020;174(1):29–37.10.1001/jamapediatrics.2019.4476690211231764962Search in Google Scholar

25. Simpson EL, Paller AS, Siegfried EC, Boguniewicz M, Sher L, Gooderham MJ, et al. Efficacy and Safety of Dupilumab in Adolescents with Uncontrolled Moderate to Severe Atopic Dermatitis: A Phase 3 Randomized Clinical Trial. JAMA Dermatology. 2020;156(1):44–56.10.1001/jamadermatol.2019.3336686526531693077Search in Google Scholar